As indicated by a recently concluded study, almost half of patients who did complete 56 weeks of treatment with Orexigen Therapeutics Inc’s experimental obesity treatment, Contrave, lost no less than 10 percent of their weight in a late-stage study and the drug was also found to help cholesterol and blood sugar levels. What is more, the drug did bring forth the reality that an even greater development in non- weight loss measures in patients considered to be at high risk of heart disease is possible.
More »

There was a time when even the epochal developments in the realm of health used to go unsung, but no more. There is the mighty presence of Bill & Melinda Gates Foundation these days and the globally acclaimed organization, for this time, has annunciated 76 grants of US$100,000 each so as to pursue ideas for transforming health in developing countries.
More »